{
  "documentMetadata": {
    "title": "Vibrio vulnificus, V. alginolyticus, V. damsela",
    "lastUpdated": "2025-02-06",
    "sourceFile": "Vibrio vulnificus, V. alginolyticus, V. damsela.pdf"
  },
  "content": [
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Clinical Setting"
        },
        {
          "type": "list",
          "items": [
            "Recommendations are for treatment of severe soft tissue infection and sepsis.",
            "Vibrio vulnificus is a gram-negative bacillus that can cause diarrhea, wound infections, and bacteremia. It is the number one cause of shellfish-associated deaths in the U.S. (Eur J Clin Microbiol Infect Dis 2019;38:1999).",
            "Organisms live in salt water marine environments: seawater and estuaries; wound infections result from exposure of a wound to seawater or brackish water containing the organism. Exposure can result from recreational water activities, oyster shucking, sea urchin harvesting, fish fin punctures or handling seafood.",
            "Wound infections are most common during the summer months when the density of organisms is greatest and can progress to necrotizing fasciitis (J Antimicrob Chemother 67:488, 2012).",
            "Highest risk factors for life-threatening infection:",
            "Cirrhosis due to alcohol or chronic viral hepatitis, alcoholism, hemochromatosis, diabetes mellitus, thalassemia major, chronic renal disease, use of TNF inhibitors, and lymphoma (Clin Infect Dis 46:970, 2008).",
            "General references: N Engl J Med 2018;379:375 (image of hemorrhagic bullae); N Engl J Med 2016;375:1780"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Etiologies"
        },
        {
          "type": "list",
          "items": [
            "Vibrio vulnificus",
            "Vibrio alginolyticus",
            "Vibrio damsela (aka Photobacterium damselae)"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Primary Regimens"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult"
            },
            "components": [
              {
                "drug": "Doxycycline",
                "dose": "100 mg",
                "route": "IV/po",
                "frequency": "bid",
                "connector": "or"
              },
              {
                "drug": "Minocycline",
                "dose": "100 mg",
                "route": "IV/po",
                "frequency": "bid",
                "connector": "+"
              },
              {
                "drug": "Ceftriaxone",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "once daily",
                "connector": "or"
              },
              {
                "drug": "Ceftazidime",
                "dose": "1 gm",
                "route": "IV",
                "frequency": "q8h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Child"
            },
            "components": [
              {
                "drug": "Doxycycline",
                "dose": "4.4 mg/kg/day",
                "route": "div bid",
                "notes": "(max 200 mg/day)",
                "connector": "+"
              },
              {
                "drug": "Ceftazidime",
                "dose": "150-200 mg/kg/d",
                "route": "divided q8h"
              }
            ],
            "notes": "NOTE: Doxycycline can be safely administered for up to 21 days regardless of age (AAP Red Book 2018, Section 4; J Pediatr 166:1246, 2015)."
          }
        },
        {
          "type": "list",
          "items": [
            "Severe infections may require surgical debridement: Am J Surg 206: 32, 2013."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Alternative Regimens"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Levofloxacin",
                "dose": "750 mg",
                "route": "IV/po",
                "frequency": "once daily",
                "connector": "or"
              },
              {
                "drug": "Ciprofloxacin",
                "dose": "750 mg",
                "route": "po bid",
                "connector": "or"
              },
              {
                "drug": "Ciprofloxacin",
                "dose": "400 mg",
                "route": "IV bid",
                "notes": "can be substituted for Doxycycline or Minocycline (See Comments)"
              }
            ]
          }
        },
        {
          "type": "list",
          "items": [
            "Minor infections can be treated with a single agent."
          ]
        }
      ]
    },
    {
      "type": 'nestedContent',
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Antimicrobial Stewardship"
        },
        {
          "type": "list",
          "items": [
            "Duration of therapy based on clinical response."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Comments"
        },
        {
          "type": "list",
          "items": [
            "Retrospective surveillance study found higher mortality with ß-lactam alone compared to fluoroquinolone alone or combination of fluoroquinolone or a tetracycline plus ß-lactam (BMC Infect Dis. 5:226, 2015).",
            "Due to the potential severity of disease, it is suggested that with the appropriate risk factors (ingestion of raw seafood, exposure to salt-water environment) empiric therapy for wound and septic patients include drugs active against V. vulnificus.",
            "Roughly 75% of patients have bullous skin lesions.",
            "Sepsis and septic shock in immunocompromised individuals, including hematological disease, malignancy, and liver disease (Epidemiol Infect 142:877, 2014).",
            "Review comparing different Vibrio infections (Nat Rev Dis Primers 4:8 2018).",
            "Reference: StatPearls; 2023 Jan. 2023 Jan 10."
          ]
        }
      ]
    }
  ]
}
